Organization
University of Oxford, Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford, United Kingdom
3 abstracts
Abstract
ASSOCIATION BETWEEN PATIENT-REPORTED PAIN AND ACHIEVING REMISSION OR LOW DISEASE ACTIVITY AT 3 MONTHS IN PATIENTS WITH RHEUMATOID ARTHRITIS FROM THE RA-BE-REAL STUDYOrg: University of Oxford, Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford, United Kingdom, Eli Lilly and Company, Indianapolis IN, United States of America, Sorbonne University, Department of Rheumatology, Assistance Publique Hospitaux de Paris, Pitie Salpetriere Hospital,, Paris, France, Schlosspark Klinik, Department of Internal Medicine and Rheumatology,, Berlin, Germany, Griffith University, Department of Medicine at the University of Queensland, at the School of Medicine, Queensland, Australia,
Abstract
BARICITINIB PROVIDES GREATER IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES ACROSS ALL DISEASE ACTIVITY LEVELS COMPARED TO PLACEBO AND ADALIMUMAB IN RHEUMATOID ARTHRITISOrg: University of Oxford, Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford, United Kingdom, Hospital Universitario Marqués de Valdecilla, Department of Rheumatology, Santander, Spain, Chiba University Hospital, Department of Allergy and Clinical Immunology, Chiba, Japan, Eli Lilly and Company, Lilly Research Laboratories, Indianapolis, United States of America, Sorbonne University – Assistance Publique Hôpitaux de Paris, Pitie Salpetriere Hospital, Rheumatology Department, Paris, France,
Abstract
Back pain and morning stiffness as mediators of tofacitinib treatment effect on fatigue in patients with ankylosing spondylitis: a mediation analysisOrg: Copenhagen University Hospital, Bispebjerg and Frederiksberg, The Parker Institute, Copenhagen, Denmark, University of Oxford, Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford, United Kingdom, University Hospital La Paz, IdiPaz, Madrid, Spain, Case Western Reserve University, Division of Rheumatology, Cleveland, OH, United States of America, Pfizer Inc, Inflammation and Immunology, Groton, CT, United States of America,